Selected research
Market Structure
Global Automated DNA Sequencers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Automated DNA Sequencers market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Automated DNA Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Automated DNA Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Automated DNA Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Automated DNA Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Automated DNA Sequencers include Roche, Thermo Fisher Scientific, Illumina, Danaher, Agilent Technologies, Beckman Coulter, Abbott Molecular, Promega and QIAGEN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Automated DNA Sequencers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Automated DNA Sequencers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Automated DNA Sequencers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Automated DNA Sequencers market size, projected growth trends, production technologies, key applications, and end-use industries.
Automated DNA Sequencers Segment by Company
Roche
Thermo Fisher Scientific
Illumina
Danaher
Agilent Technologies
Beckman Coulter
Abbott Molecular
Promega
QIAGEN
Oxford Nanopore Technologies
BGI Group
Berry Genomics
Shanghai Xinzhen
CapitalBio Technology
Automated DNA Sequencers Segment by Type
Chain Terminator DNA Sequencing
Next Generation DNA Sequencing
Automated DNA Sequencers Segment by Application
Pharmaceutical and Biotechnology
Hospitals and Clinics
Scientific Research
Automated DNA Sequencers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated DNA Sequencers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automated DNA Sequencers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated DNA Sequencers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Automated DNA Sequencers market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Automated DNA Sequencers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Automated DNA Sequencers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Automated DNA Sequencers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Chain Terminator DNA Sequencing
- Next Generation DNA Sequencing
Applications
- Pharmaceutical and Biotechnology
- Hospitals and Clinics
- Scientific Research
Companies covered
- Roche
- Thermo Fisher Scientific
- Illumina
- Danaher
- Agilent Technologies
- Beckman Coulter
- Abbott Molecular
- Promega
- QIAGEN
- Oxford Nanopore Technologies
- BGI Group
- Berry Genomics
- Shanghai Xinzhen
- CapitalBio Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Automated DNA Sequencers Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Automated DNA Sequencers Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Automated DNA Sequencers Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Automated DNA Sequencers Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Automated DNA Sequencers Market Dynamics
- 2.1 Automated DNA Sequencers Industry Trends
- 2.2 Automated DNA Sequencers Industry Drivers
- 2.3 Automated DNA Sequencers Industry Opportunities and Challenges
- 2.4 Automated DNA Sequencers Industry Restraints
3 Automated DNA Sequencers Market by Manufacturers
- 3.1 Global Automated DNA Sequencers Revenue by Manufacturers (2021-2026)
- 3.2 Global Automated DNA Sequencers Sales by Manufacturers (2021-2026)
- 3.3 Global Automated DNA Sequencers Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Automated DNA Sequencers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Automated DNA Sequencers Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Automated DNA Sequencers Manufacturers, Product Type & Application
- 3.7 Global Automated DNA Sequencers Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Automated DNA Sequencers Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Automated DNA Sequencers Players Market Share by Revenue in 2025
- 3.8.3 2025 Automated DNA Sequencers Tier 1, Tier 2, and Tier 3
4 Automated DNA Sequencers Market by Type
- 4.1 Automated DNA Sequencers Type Introduction
- 4.1.1 Chain Terminator DNA Sequencing
- 4.1.2 Next Generation DNA Sequencing
- 4.2 Global Automated DNA Sequencers Sales by Type
- 4.2.1 Global Automated DNA Sequencers Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Automated DNA Sequencers Sales by Type (2021-2032)
- 4.2.3 Global Automated DNA Sequencers Sales Market Share by Type (2021-2032)
- 4.3 Global Automated DNA Sequencers Revenue by Type
- 4.3.1 Global Automated DNA Sequencers Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Automated DNA Sequencers Revenue by Type (2021-2032)
- 4.3.3 Global Automated DNA Sequencers Revenue Market Share by Type (2021-2032)
5 Automated DNA Sequencers Market by Application
- 5.1 Automated DNA Sequencers Application Introduction
- 5.1.1 Pharmaceutical and Biotechnology
- 5.1.2 Hospitals and Clinics
- 5.1.3 Scientific Research
- 5.2 Global Automated DNA Sequencers Sales by Application
- 5.2.1 Global Automated DNA Sequencers Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Automated DNA Sequencers Sales by Application (2021-2032)
- 5.2.3 Global Automated DNA Sequencers Sales Market Share by Application (2021-2032)
- 5.3 Global Automated DNA Sequencers Revenue by Application
- 5.3.1 Global Automated DNA Sequencers Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Automated DNA Sequencers Revenue by Application (2021-2032)
- 5.3.3 Global Automated DNA Sequencers Revenue Market Share by Application (2021-2032)
6 Global Automated DNA Sequencers Sales by Region
- 6.1 Global Automated DNA Sequencers Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Automated DNA Sequencers Sales by Region (2021-2032)
- 6.2.1 Global Automated DNA Sequencers Sales by Region (2021-2026)
- 6.2.2 Global Automated DNA Sequencers Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Automated DNA Sequencers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Automated DNA Sequencers Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Automated DNA Sequencers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Automated DNA Sequencers Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Automated DNA Sequencers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Automated DNA Sequencers Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Automated DNA Sequencers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Automated DNA Sequencers Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Automated DNA Sequencers Revenue by Region
- 7.1 Global Automated DNA Sequencers Revenue by Region
- 7.1.1 Global Automated DNA Sequencers Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Automated DNA Sequencers Revenue by Region (2021-2026)
- 7.1.3 Global Automated DNA Sequencers Revenue by Region (2027-2032)
- 7.1.4 Global Automated DNA Sequencers Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Automated DNA Sequencers Revenue (2021-2032)
- 7.2.2 North America Automated DNA Sequencers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Automated DNA Sequencers Revenue (2021-2032)
- 7.3.2 Europe Automated DNA Sequencers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Automated DNA Sequencers Revenue (2021-2032)
- 7.4.2 Asia-Pacific Automated DNA Sequencers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Automated DNA Sequencers Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Automated DNA Sequencers Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Roche
- 8.1.1 Roche Company Information
- 8.1.2 Roche Business Overview
- 8.1.3 Roche Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Roche Automated DNA Sequencers Product Portfolio
- 8.1.5 Roche Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Automated DNA Sequencers Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Illumina
- 8.3.1 Illumina Company Information
- 8.3.2 Illumina Business Overview
- 8.3.3 Illumina Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Illumina Automated DNA Sequencers Product Portfolio
- 8.3.5 Illumina Recent Developments
- 8.4 Danaher
- 8.4.1 Danaher Company Information
- 8.4.2 Danaher Business Overview
- 8.4.3 Danaher Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Danaher Automated DNA Sequencers Product Portfolio
- 8.4.5 Danaher Recent Developments
- 8.5 Agilent Technologies
- 8.5.1 Agilent Technologies Company Information
- 8.5.2 Agilent Technologies Business Overview
- 8.5.3 Agilent Technologies Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Agilent Technologies Automated DNA Sequencers Product Portfolio
- 8.5.5 Agilent Technologies Recent Developments
- 8.6 Beckman Coulter
- 8.6.1 Beckman Coulter Company Information
- 8.6.2 Beckman Coulter Business Overview
- 8.6.3 Beckman Coulter Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Beckman Coulter Automated DNA Sequencers Product Portfolio
- 8.6.5 Beckman Coulter Recent Developments
- 8.7 Abbott Molecular
- 8.7.1 Abbott Molecular Company Information
- 8.7.2 Abbott Molecular Business Overview
- 8.7.3 Abbott Molecular Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Abbott Molecular Automated DNA Sequencers Product Portfolio
- 8.7.5 Abbott Molecular Recent Developments
- 8.8 Promega
- 8.8.1 Promega Company Information
- 8.8.2 Promega Business Overview
- 8.8.3 Promega Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Promega Automated DNA Sequencers Product Portfolio
- 8.8.5 Promega Recent Developments
- 8.9 QIAGEN
- 8.9.1 QIAGEN Company Information
- 8.9.2 QIAGEN Business Overview
- 8.9.3 QIAGEN Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 QIAGEN Automated DNA Sequencers Product Portfolio
- 8.9.5 QIAGEN Recent Developments
- 8.10 Oxford Nanopore Technologies
- 8.10.1 Oxford Nanopore Technologies Company Information
- 8.10.2 Oxford Nanopore Technologies Business Overview
- 8.10.3 Oxford Nanopore Technologies Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Oxford Nanopore Technologies Automated DNA Sequencers Product Portfolio
- 8.10.5 Oxford Nanopore Technologies Recent Developments
- 8.11 BGI Group
- 8.11.1 BGI Group Company Information
- 8.11.2 BGI Group Business Overview
- 8.11.3 BGI Group Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 BGI Group Automated DNA Sequencers Product Portfolio
- 8.11.5 BGI Group Recent Developments
- 8.12 Berry Genomics
- 8.12.1 Berry Genomics Company Information
- 8.12.2 Berry Genomics Business Overview
- 8.12.3 Berry Genomics Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Berry Genomics Automated DNA Sequencers Product Portfolio
- 8.12.5 Berry Genomics Recent Developments
- 8.13 Shanghai Xinzhen
- 8.13.1 Shanghai Xinzhen Company Information
- 8.13.2 Shanghai Xinzhen Business Overview
- 8.13.3 Shanghai Xinzhen Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Shanghai Xinzhen Automated DNA Sequencers Product Portfolio
- 8.13.5 Shanghai Xinzhen Recent Developments
- 8.14 CapitalBio Technology
- 8.14.1 CapitalBio Technology Company Information
- 8.14.2 CapitalBio Technology Business Overview
- 8.14.3 CapitalBio Technology Automated DNA Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 CapitalBio Technology Automated DNA Sequencers Product Portfolio
- 8.14.5 CapitalBio Technology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Automated DNA Sequencers Value Chain Analysis
- 9.1.1 Automated DNA Sequencers Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Automated DNA Sequencers Production Mode & Process
- 9.2 Automated DNA Sequencers Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Automated DNA Sequencers Distributors
- 9.2.3 Automated DNA Sequencers Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst